1. Home
  2. SUPN vs AVA Comparison

SUPN vs AVA Comparison

Compare SUPN & AVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$48.78

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo Avista Corporation

AVA

Avista Corporation

N/A

Current Price

$39.25

Market Cap

3.3B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
AVA
Founded
2005
1889
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Power Generation
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
2010
1994

Fundamental Metrics

Financial Performance
Metric
SUPN
AVA
Price
$48.78
$39.25
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$61.60
$38.67
AVG Volume (30 Days)
706.9K
591.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
5.11%
EPS Growth
N/A
3.93
EPS
N/A
2.38
Revenue
$392,755,000.00
$1,964,000,000.00
Revenue This Year
$23.19
$0.20
Revenue Next Year
$17.65
$4.12
P/E Ratio
N/A
$16.12
Revenue Growth
N/A
1.34
52 Week Low
$29.16
$35.50
52 Week High
$59.68
$43.50

Technical Indicators

Market Signals
Indicator
SUPN
AVA
Relative Strength Index (RSI) 40.78 44.11
Support Level $47.95 $36.78
Resistance Level $52.14 $39.34
Average True Range (ATR) 1.99 0.74
MACD -0.57 -0.06
Stochastic Oscillator 22.57 50.55

Price Performance

Historical Comparison
SUPN
AVA

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

Share on Social Networks: